Lestrem, France (ots/PRNewswire) - Reinforces position as a supplier of excipients and raw materials for the pharmaceutical and biopharmaceutical industries Roquette, a global leader in innovative plant-based pharmaceutical ingredients, announces its commitment to provide new product offerings to address the growing demand for excipients and raw materials for the biopharmaceutical market. (Logo: ...
Darmstadt, Germany (ots/PRNewswire) - - Merck integrates innovative Eeva® Test with Geri(TM) incubation platform, bringing individualized incubation and outcome prediction together - Geri(TM) humidity technology aims to further advance incubation to precisely monitor and manage the humidity level in the incubator Merck, a leading science and technology company, today ...
Kaiseraugst, Switzerland (ots/PRNewswire) - - Breakthrough for animal nutrition to reduce impact on ocean resources and making it more sustainable - Commercial-scale facility for algal oil for salmon aquaculture and pet food to be built in the United States - Further develop and produce a high value algal oil with a ...
Milan (ots/PRNewswire) - GfK's sales tracking of four key European retail optics markets (Italy, France, Spain and Germany), shows a turnover of EUR17.6 billion for total year 2016. This is a sales value growth of 0.9 percent compared to the previous year. GfK released the findings at the international MIDO 2017 trade fair in Milan. GfK tracks sales data in the optician channel for sunglasses, frames, spectacle lenses, ...
Ballerup, Denmark and Orlando, Florida (ots/PRNewswire) - LEO Pharma today announced positive results from a Phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to severe atopic dermatitis (AD), a serious and chronic form of eczema. Tralokinumab is an investigational ...
Sunnyvale, California (ots/PRNewswire) - The Internet is one of the first places patients turn to for healthcare information after receiving a cancer diagnosis, according to the American Cancer Society. Accuray Incorporated (NASDAQ: ARAY) is launching http://www.cyberknife.com and http://www.tomotherapy.com to provide an additional resource for cancer patients to turn to for information about their disease and potential ...
Amsterdam and Vienna (ots/PRNewswire) - - iDose[4] proprietary reconstruction technique lowers operating costs by increasing tube life - iFlow intelligent workflow platform enables consistent image quality from operator-to-operator to reduce rescans Royal Philips (http://www.philips.com/) (NYSE: PHG; AEX: PHIA) ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - More patients now able to receive a standard-of-care treatment with Erbitux plus FOLFIRI or FOLFOX - NICE's recommendation is a significant step forward in Merck's aspiration to ensure cancer patients have optimal access to effective ...
Amsterdam and Vienna (ots/PRNewswire) - Royal Philips (http://www.usa.philips.com/) (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled new advanced radiology solutions at the 2017 European Congress of Radiology (https://www.myesr.org/ecr-2017) (ECR), beginning March 1 at the Austria Center ...
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US and UK-based media - Second Biologics License Application accepted by the FDA for avelumab - Prognosis for urothelial carcinoma is currently poor, particularly when the disease has metastasized Merck and Pfizer Inc. today announced that the US ...
Hørsholm, Denmark (ots/PRNewswire) - ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF) today announced that for the first time, allergy immunotherapy is now recommended as a treatment option in the Global Initiative for Asthma (GINA) report: Global Strategy for Asthma Management and Prevention. This global strategy is a ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. and UK based media - Ready-to-use pre-filled pen provides a convenient treatment option for patients - Simplified injection device for self-administration comes in multiple doses, addressing individual needs of patients Merck, a leading science and technology company, today announced that the European ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - This Press Release is intended for Global Use If approved, Natpar would be the first licensed recombinant parathyroid hormone in Europe for the management of chronic hypoparathyroidism, the only endocrine-deficiency disorder with no hormone treatment[1] Shire plc (LSE: SHP, ...
Berlin (ots/PRNewswire) - Tillotts Pharma is strengthening its presence in the German market: the Berlin office was opened in January 2017 under the management of Magdalena Kritikos. The portfolio includes Entocort® for the treatment of Crohn's disease, Asacol® for the treatment of ulcerative colitis, and VistaPrep® for bowel preparation before endoscopy. With ...
Amsterdam (ots/PRNewswire) - - Developed in collaboration with leading hospitals worldwide, Philips Azurion (https://www.usa.philips.com/healthcare/resources/landing/azurion) is an innovative image-guided therapy platform that allows clinicians to easily and confidently perform a wide range of routine and complex ...
Amsterdam (ots/PRNewswire) - myTomorrows announces that Ashley Vinson, former Head of Brand Strategy at Twitter, joins the company as Chief Marketing Officer. Robert-Jan Sips, who previously led IBM's European Centers for Advanced Studies, has been appointed Chief Technology Officer. Supporting the company's marketplace vision, Ashley and Robert-Jan will lead the expansion of myTomorrows' ongoing mission to connect ...
Seattle (ots/PRNewswire) - - First Detailed Results from SWORD Clinical Trial Program Show Investigational Two-drug Combination as Effective as Three- or Four-drug Regimens as Maintenance Therapy in Patients who have Already Achieved Viral Suppression Janssen Sciences Ireland UC (Janssen) announced positive results ...
Darmstadt, Germany (ots/PRNewswire) - - Post hoc analysis of Phase III CLARITY study data recently published in Multiple Sclerosis Journal showed statistically significant reduction in brain atrophy in patients on a short course of investigational Cladribine Tablets over two years compared with patients receiving placebo - These findings correlated with effects on ...
Québec, Canada/Lausanne, Switzerland (ots) - GenePOC announces the commercialization of its Clostridium difficile and Group B Strep molecular tests in Europe, along with onboarding additional partners to cover the EMEA market GenePOC, Inc. (GenePOC) a member of the Debiopharm Group is proud to announce that it has started the commercialization of its first two CE-IVD marked tests, GenePOC(TM) CDiff and GenePOC(TM) GBS ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - Shire presentations at EAHAD 2017 underscore the company's leadership in improving global standards of care Shire plc (LSE: SHP, NASDAQ: SHPG), the leading biotechnology company focused on serving individuals with rare diseases, presented its new estimate of the Global Annual Bleed Rate (GABR), an effort to build on current global ...
Paris (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Poster #P024 Patient preference data presented today at the 10th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) demonstrated the ...
Wevelgem, Belgium (ots/PRNewswire) - Jacoti Hearing Suite, an innovative set of hearing applications created by Jacoti bvba, has been named a Global Mobile Awards 2017 Nominee. Products entered in this prestigious program are judged by a preeminent panel of more than 250 independent judges from across the world, ...
Dublin (ots/PRNewswire) - -- Allergan enters skin quality category with new injectable product using VYCROSS® technology[1] for use on the face, neck, décolletage and hands[2] -- Hyaluronic Acid (HA) gel designed to improve skin's smoothness (absence of fine lines), hydration and elasticity for up to nine months ...
Calgary, Alberta (ots/PRNewswire) - Several Key Proteins That Drive Kidney (Renal) Disease and Dialysis Risk are Downregulated After a Single Dose of Apabetalone Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) today announced preliminary results from the New Zealand based Phase 1 trial with severe kidney (renal) impaired patients. The data showed ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. based media - Merck is broadening its efforts to support ART clinics to achieve excellence for patients - Through leading edge education and training, the Centre of Excellence aims to support clinics to achieve consistent and high level of outcome Merck, a leading science and technology company, today announced the opening of its first Centre of Excellence (CoE) ...
International Union Against Cancer (UICC)
Davos, Switzerland (ots/PRNewswire) - - New city-level initiative launched in partnership between the Union for International Cancer Control (UICC), the World Economic Forum and World Bank - A commitment to saving lives by helping country and city leaders improve the health of their citizens and reduce inequities in access to quality cancer treatment and care - A ...
Dublin (ots/PRNewswire) - DS Biopharma (DS), a privately held, clinical stage, pharmaceutical drug discovery and development company, today announced that recruitment has begun in two separate Phase 2b atopic dermatitis (AD) studies with its lead compound DS107. An Oral DS107 Phase 2b study (called 'ADvance') in 300 ...
Tokyo and Haifa, Israel (ots/PRNewswire) - INSIGHTEC (http://www.insightec.com/JP/), the leader in MR-guided Focused Ultrasound (MRgFUS) therapy, announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its Exablate Neuro system for the non-invasive treatment of essential tremor in ...
Sunnyvale, California (ots/PRNewswire) - Practice-Changing Study Presented at the 2016 Best of ASTRO Meeting Accuray Incorporated (NASDAQ: ARAY) announced today new data showing that 80 percent of patients with solitary plasmacytoma of the bone (SPB) had excellent cancer control four years after receiving ...
Aachen / Pisa (ots) - Grünenthal receives Breakthrough Therapy Designation from U.S. FDA for neridronic acid for the treatment of complex regional pain syndrome (CRPS), a debilitating orphan disease with high medical need - Neridronic acid is the first investigational medicine to receive Breakthrough Therapy ...